Reduced Length of Hospital Stay for Mini-Invasive Aortic Valve Replacements after implementation of an Enhanced Recovery After Surgery Program
Pierre OSES, Sr., Cedrick Zaouter, Jocelyn Duchateau, Alexandre Ouattara, Louis Labrousse.
Bordeaux University Hospital, PESSAC, France.
OBJECTIVE: There is presently a warm enthusiasm for enhanced recovery after surgery (ERAS) program. A recent review indicates that length of hospital stay and postoperative complication could be reduced by 30 and 50%, respectively. However, most of the studies analyzed encompassed solely colorectal and orthopedic surgeries. Only one retrospective ERAS program has been described for mini-invasive cardiac surgery. Thus, in an effort to provide more evidence to the literature we have investigated prospectively the feasibility and clinical effectiveness of a dedicated ERAS program for mini-invasive Aortic Valve Replacements (AVR).
METHODS: Data were collected prospectively from consecutive patients scheduled for an AVR via a ministernotomy during 2 time periods, before (PRE-AVRERAS group) and after application of a dedicated ERAS pathway specifically designed for this mini-invasive cardiac procedure (AVRERAS group). Operative data, postoperative morphine consumption, postoperative data of interest, postoperative infection rates, types and rate of complications, 30-day type and rates of readmission were collected
RESULTS: There were 22 patients in the PRE-AVRERAS group, and 14 in the AVRERAS group. The median length of hospital stay was 9 days in the PRE-AVRERAS group compared to 5 days the AVRERAS group (P < 0.05). The results of postoperative interest are described in table 1. An ERAS pathway envisioned for mini-invasive AVR seems feasible and associated with a shorter length of hospital stay.
CONCLUSIONS: Our study indicates that an ERAS pathway could be implemented effectively with interesting results when a mini-invasive AVR is planned.
|PRE¬-AVRERAS (n=22)||AVRERAS (n=14)||P¬Value|
|Cross clamp time min.||68±15.5||41±8.2||0.002|
|Sutureless valve implantation n(%)||0||14(100)||<0.001|
|Postoperative morphine consumption||8±10||3±3||0.079|
|Mobilization on a chair on the day of the surgery; n(%)||0(0)||11(79)||< 0.001|
|Transurethral catheter removal on the morning after surgery n(%)||1(4.5)||9(64)||<0.001|
|Overall infections during the hospitalization; n(%)||8(36)||1(7)||0.06|
|Readmission for cardiac reasons; n(%)||2(9)||0(0)||0.51|
|Extubation in operative room n(%)||0||13(92.8)||<0.001|
Back to 2016 Annual Meeting Posters